V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007637 | 310004815 | 1.77 | 69 | Curative (C) | 2013-12-10 | 2013-12-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310018981 | UKALL2011 |
| 310007638 | 310004815 | 1.77 | null | Palliative (P) | 2015-05-31 | 2015-05-31 | Bexarotene | N | N | 310018981 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007639 | 310004817 | 1.51 | 56.2 | Curative (C) | null | 2016-08-14 | Docetaxel + Gemcitabine with GCSF | N | N | 310018992 | DOCETAXEL + GEMCITABINE |
| 310007640 | 310004818 | 1.59 | 60.6 | Palliative (P) | 2016-02-19 | 2016-03-25 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 310018995 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007641 | 310004820 | null | 108.3 | Curative (C) | 2016-02-13 | 2016-07-16 | Methotrexate intrathecal | 2 | N | 310018997 | METHOTREXATE INTRATHECAL |
| 310007642 | 310004820 | null | 72.5 | null | 2014-10-24 | 2014-10-31 | Carboplatin + Etoposide iv&po | 02 | null | 310018997 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007643 | 310008075 | null | null | Curative (C) | 2013-03-14 | 2014-03-24 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310018998 | CISPLATIN + RT |
| 310007644 | 310004824 | 1.58 | 81.1 | Curative (C) | 2017-10-23 | 2017-11-01 | CHOP R - 21 days | 02 | N | 310019005 | CHOP R |
| 310007645 | 310009796 | 1.67 | 89 | Disease modification (D) | 2014-01-15 | 2014-02-15 | Rituximab | N | null | 310019013 | RITUXIMAB |
| 310007646 | 310009796 | 1.69 | 54.5 | Disease modification (D) | 2016-02-16 | 2016-02-26 | Cyclophosphamide oral | N | N | 310019013 | CYCLOPHOSPHAMIDE |
| 310007647 | 310009796 | 1.56 | 53 | Palliative (P) | 2017-09-02 | 2017-09-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310019013 | BEXAROTENE |
| 310007648 | 310004826 | 1.65 | null | Curative (C) | 2015-01-26 | 2015-02-02 | Cisplatin + Radiotherapy | N | N | 310019024 | CISPLATIN + RT |
| 310007649 | 310004826 | 1.77 | null | Palliative (P) | 2015-08-22 | 2015-09-16 | DOCETAXEL + GEMCITABINE | 99 | N | 310019024 | DOCETAXEL + GEMCITABINE |
| 310007651 | 310004828 | 1.69 | 20.2 | Palliative (P) | 2017-03-31 | 2017-03-31 | Ipilimumab | 02 | N | 310019035 | IPILIMUMAB |
| 310007652 | 310004829 | 1.8 | 71.3 | Curative (C) | 2014-04-21 | 2014-05-29 | Methotrexate intrathecal | 2 | N | 310019036 | METHOTREXATE INTRATHECAL |
| 310007653 | 310008080 | 1.69 | 76.9 | Palliative (P) | 2016-01-22 | 2016-05-02 | Docetaxel 75mg/m2 (21 day) | N | N | 310019037 | DOCETAXEL |
| 310007654 | 310008080 | null | 59.3 | Not known (9) | 2017-10-08 | 2017-10-10 | Etoposide oral | N | N | 310019037 | ETOPOSIDE |
| 310007655 | 310004837 | 1.78 | 85.3 | Palliative (P) | 2016-07-28 | 2016-07-28 | Cisplatin | 02 | N | 310019045 | CISPLATIN |
| 310007656 | 310004838 | 1.41 | 78.3 | null | 2016-09-19 | 2016-09-19 | Rituximab | 2 | N | 310019048 | RITUXIMAB |
| 310007657 | 310008085 | 1.58 | 51.6 | null | null | 2014-06-22 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310019052 | DOCETAXEL |
| 310007658 | 310004840 | 1.79 | 66 | Curative (C) | 2014-05-07 | 2014-05-11 | Cisplatin + Radiotherapy | 02 | N | 310019058 | CISPLATIN + RT |
| 310007659 | 310008086 | null | 84.6 | Curative (C) | 2018-01-17 | 2018-01-22 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310019068 | CISPLATIN + RT |
| 310007660 | 310004844 | 1.73 | 51 | Palliative (P) | 2018-04-25 | 2018-05-02 | Docetaxel | N | N | 310019068 | DOCETAXEL |
| 310007661 | 310004844 | 1.8 | 97 | Curative (C) | 2013-12-13 | 2013-12-19 | Bexarotene | N | N | 310019068 | CARBOPLATIN + ETOPOSIDE |
| 310007662 | 310004845 | 1.77 | 76.8 | Adjuvant (A) | null | 2016-09-12 | Cisplatin + Radiotherapy | N | N | 310019076 | CISPLATIN + RT |
| 310007663 | 310008088 | 1.68 | 79.599 | Palliative (P) | 2018-05-11 | 2018-05-19 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310019076 | DOCETAXEL + GEMCITABINE |
| 310007664 | 310004847 | 1.59 | 54 | null | 2016-10-08 | 2016-10-15 | Carboplatin + Etoposide iv&po | N | N | 310019087 | ESHAP |
| 310007665 | 310004849 | null | 100.4 | Not known (9) | 2016-06-21 | 2016-06-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310019096 | DOCETAXEL |
| 310007667 | 310004851 | 1.67 | 59.8 | Palliative (P) | 2016-07-14 | 2016-07-15 | Ipilimumab | Y | N | 310019100 | IPILIMUMAB |
| 310007670 | 310004855 | 1.57 | 69.9 | Disease modification (D) | 2015-11-28 | 2015-11-29 | Bexarotene | 02 | N | 310019116 | UKALL2011 |
| 310007671 | 310004856 | 1.64 | 68.4 | Curative (C) | 2017-11-13 | 2017-11-13 | GDP | 02 | N | 310019118 | GDP |
| 310007672 | 310008093 | 0 | 83.3 | Disease modification (D) | 2015-10-16 | 2015-10-16 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | N | 310019122 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007673 | 310004857 | 170 | null | Curative (C) | 2016-11-19 | 2016-11-25 | Ipilimumab | N | N | 310019127 | IPILIMUMAB |
| 310007674 | 310004858 | null | 83.7 | Palliative (P) | 2015-01-17 | 2015-05-21 | Cisplatin | Y | N | 310019129 | CISPLATIN |
| 310007675 | 310008094 | 1.64 | 77 | Curative (C) | 2015-08-22 | 2015-08-22 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019130 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007676 | 310004860 | 1.55 | null | Adjuvant (A) | 2017-10-23 | 2017-10-26 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019131 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007677 | 310008095 | 1.75 | 62.7 | Palliative (P) | null | 2016-02-04 | Rituximab | N | N | 310019133 | RITUXIMAB |
| 310007678 | 310004861 | 1.62 | 71.3 | Palliative (P) | 2017-02-19 | 2017-05-09 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 310019138 | UKALL2011 |
| 310007679 | 310004862 | 1.71 | 57.5 | Not known (9) | 2014-03-01 | 2014-03-01 | Cyclophosphamide High Dose | 02 | N | 310019139 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007680 | 310008097 | 1.67 | 113.6 | Palliative (P) | 2014-10-12 | 2014-10-13 | Bexarotene | N | Y | 310019139 | ESHAP |
| 310007681 | 310004866 | 1.82 | 59.8 | Disease modification (D) | 2016-04-16 | 2016-04-29 | Ipilimumab | N | N | 310019145 | IPILIMUMAB |
| 310007682 | 310004868 | 1.79 | 77.4 | Neo-adjuvant (N) | 2015-06-05 | 2015-09-14 | Carboplatin + Etoposide IV 3 day | N | N | 310019151 | BEXAROTENE |
| 310007683 | 310004868 | 1.7 | 69 | Palliative (P) | 2018-03-27 | 2018-03-29 | Ipilimumab | N | N | 310019151 | IPILIMUMAB |
| 310007684 | 310004868 | 1.77 | 91.7 | Palliative (P) | 2015-10-26 | 2015-10-26 | CYCLOPHOSPHAMIDE | 02 | N | 310019151 | CYCLOPHOSPHAMIDE |
| 310007685 | 310004869 | 1.7 | 67 | Palliative (P) | 2014-08-03 | 2015-09-17 | Rituximab | 2 | N | 310019156 | RITUXIMAB |
| 310007686 | 310008099 | null | 68 | Palliative (P) | null | 2013-10-21 | Methotrexate intrathecal | N | N | 310019167 | METHOTREXATE INTRATHECAL |
| 310007687 | 310004870 | 1.6 | 50.3 | Palliative (P) | 2015-09-05 | 2015-09-07 | Cisplatin + Radiotherapy | 2 | N | 310019175 | CISPLATIN + RT |
| 310007688 | 310004870 | 1.5 | 108.3 | Palliative (P) | 2015-10-30 | 2015-10-30 | Ipilimumab | N | N | 310019175 | IPILIMUMAB |
| 310007689 | 310004871 | 1.7 | 69.65 | Palliative (P) | 2016-05-30 | 2016-06-30 | CARBOPLATIN + ETOPOSIDE | N | N | 310019181 | UKALL2011 |
| 310007690 | 310004872 | null | 96 | Palliative (P) | 2017-11-23 | 2017-12-23 | Ipilimumab | N | N | 310019190 | IPILIMUMAB |